Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  SHENZHEN STOCK EXCHANGE  >  Chongqing Zhifei Biological Products Co.,Ltd.    300122   CNE100000V20

CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO.,LTD.

(300122)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shenzhen Stock Exchange
01/18/2021 01/19/2021 01/20/2021 01/21/2021 01/22/2021 Date
141.25 132.3 142.1 150.9 164 Last
11383880 22371290 20036720 22676460 32288650 Volume
-1.84% -6.34% +7.41% +6.19% +8.68% Change
Financials
Sales 2020 15 080 M 2 327 M 2 327 M
Net income 2020 3 349 M 517 M 517 M
Net Debt 2020 1 206 M 186 M 186 M
P/E ratio 2020 78,3x
Yield 2020 0,50%
Sales 2021 20 073 M 3 097 M 3 097 M
Net income 2021 4 837 M 746 M 746 M
Net Debt 2021 1 275 M 197 M 197 M
P/E ratio 2021 54,2x
Yield 2021 0,63%
Capitalization 262 B 40 484 M 40 488 M
EV / Sales 2020 17,5x
EV / Sales 2021 13,1x
Nbr of Employees 2 972
Free-Float 14,7%
More Financials
Company
Chongqing Zhifei Biological Products Co., Ltd. is a China-based company principally engaged in the research, development, production, sale and distribution of vaccine products. The Company's main products include bacterial vaccines for the prevention of meningitis and pneumonia-based bacteria, biological products for the prevision and treatment of tuberculosis, viral vaccines for the prevention of rabies virus,... 
More about the company
Notations Surperformance© of Chongqing Zhifei Biological Products Co.,Ltd.
Trading Rating : Investor Rating :
More Ratings
All news about CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO.,LTD.
2020China's CAS COVID-19 vaccine induces immune response in mid-stage tests
RE
2020MyEG Services Partners With Anhui Zhifei Longcom for Covid-19 Vaccine Distrib..
MT
2020Hong Kong stocks end higher as investors bet on vaccine progress
RE
2020China stocks end lower after U.S. House clears delisting bill
RE
2020China stocks falter as U.S. House clears delisting bill
RE
2020CHONGQING ZHIFEI BIOLOGICAL PRODUCTS : quaterly earnings release
2020FACTBOX : The race for a coronavirus vaccine
RE
2020CHONGQING ZHIFEI BIOLOGICAL PRODUCTS : half-yearly earnings release
2020CHONGQING ZHIFEI BIOLOGICAL PRODUCTS : China's Zhifei starts Phase II trial of C..
RE
2020CHONGQING ZHIFEI BIOLOGICAL PRODUCTS : Chinese firm gets approval to begin human..
RE
2020CHONGQING ZHIFEI BIOLOGICAL PRODUCTS : annual earnings release
2020NEW CHINESE BILLIONAIRES OUTPACE U.S : Hurun
RE
More news
News in other languages on CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO.,LTD.
2020CHONGQING ZHIFEI BIOLOGICAL PRODUCTS : publication des résultats trimestriels
2020CHONGQING ZHIFEI BIOLOGICAL PRODUCTS : Veröffentlichung des Quartalsergebnisses
2020CHONGQING ZHIFEI BIOLOGICAL PRODUCTS : publication des résultats semestriels
2020CHONGQING ZHIFEI BIOLOGICAL PRODUCTS : Veröffentlichung des Halbjahresergebnisse..
2020CHONGQING ZHIFEI BIOLOGICAL PRODUCTS : publication des résultats annuels
More news
Chart CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO.,LTD.
Duration : Period :
Chongqing Zhifei Biological Products Co.,Ltd. Technical Analysis Chart | 300122 | CNE100000V20 | MarketScreener
Technical analysis trends CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO.,LTD.
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 9
Average target price 199,90 CNY
Last Close Price 164,00 CNY
Spread / Highest target 32,9%
Spread / Average Target 21,9%
Spread / Lowest Target 6,83%
EPS Revisions
Managers and Directors
NameTitle
Ren Sheng Jiang Chairman & General Manager
Yu Qin Wu Chairman-Supervisory Board
Zhen Jing Li Chief Financial Officer & Director
Ling Feng Jiang Vice Chairman & Deputy General Manager
Xin Rong Zhang Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO.,LTD.10.88%40 484
CSL LIMITED-3.03%96 409
SAMSUNG BIOLOGICS CO.,LTD.-3.87%47 496
BIOGEN INC.10.04%41 462
ALEXION PHARMACEUTICALS, INC.1.04%34 956
UCB3.67%20 143